Literature DB >> 22890033

Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Zachary S Wettstein1, Michael Fleming, Aileen Y Chang, David J Copenhaver, Angela R Wateska, Sarah M Bartsch, Bruce Y Lee, Rajan P Kulkarni.   

Abstract

The burden of dengue in Nicaragua has been steadily rising during the last three decades; however, there have been few efforts to quantify the burden (measured in disability-adjusted life years [DALYs]) and cost to society. Using primary data from the Nicaraguan Ministry of Health (MINSA), the total cost and burden of dengue were calculated from 1996 to 2010. Total costs included both direct costs from medical expenditures and prevention activities and indirect costs from lost productivity. The annual disease burden ranged from 99 to 805 DALYs per million, with a majority associated with classic dengue fever. The total cost was estimated to be US$13.5 million/year (range: US$5.1-27.6 million). This analysis can help improve allocation of dengue control resources in Nicaragua and the region. As one of the most comprehensive analyses of its type to date in Nicaragua and Latin America, this study can serve as a model to determine the burden and cost of dengue.

Entities:  

Mesh:

Year:  2012        PMID: 22890033      PMCID: PMC3516309          DOI: 10.4269/ajtmh.2012.12-0146

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.

Authors:  E Harris; E Videa; L Pérez; E Sandoval; Y Téllez; M L Pérez; R Cuadra; J Rocha; W Idiaquez; R E Alonso; M A Delgado; L A Campo; F Acevedo; A Gonzalez; J J Amador; A Balmaseda
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

2.  The health and economic impact of dengue in Latin America.

Authors:  Jaime R Torres; Julio Castro
Journal:  Cad Saude Publica       Date:  2007       Impact factor: 1.632

3.  Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels.

Authors:  Danielle V Clark; Mammen P Mammen; Ananda Nisalak; Virat Puthimethee; Timothy P Endy
Journal:  Am J Trop Med Hyg       Date:  2005-06       Impact factor: 2.345

Review 4.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

5.  Disability adjusted life years lost to dengue in Brazil.

Authors:  P M Luz; B Grinsztejn; A P Galvani
Journal:  Trop Med Int Health       Date:  2009-01-20       Impact factor: 2.622

6.  High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua.

Authors:  Angel Balmaseda; Samantha N Hammond; Yolanda Tellez; Laurel Imhoff; Yoryelin Rodriguez; Saira I Saborío; Juan C Mercado; Leonel Perez; Elsa Videa; Elvis Almanza; Guillermina Kuan; Miguel Reyes; Leyla Saenz; Juan J Amador; Eva Harris
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

7.  Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama.

Authors:  Blas Armien; Jose A Suaya; Evelia Quiroz; Binod K Sah; Vicente Bayard; Loyd Marchena; Cornelio Campos; Donald S Shepard
Journal:  Am J Trop Med Hyg       Date:  2008-09       Impact factor: 2.345

Review 8.  Economic burden of dengue infections in India.

Authors:  Pankaj Garg; Jitender Nagpal; Prakash Khairnar; Suranjith L Seneviratne
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-04-09       Impact factor: 2.184

9.  Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.

Authors:  Katie B Anderson; Supamit Chunsuttiwat; Ananda Nisalak; Mammen P Mammen; Daniel H Libraty; Alan L Rothman; Sharone Green; David W Vaughn; Francis A Ennis; Timothy P Endy
Journal:  Lancet       Date:  2007-04-28       Impact factor: 79.321

10.  The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination.

Authors:  Peter J Hotez; Maria Elena Bottazzi; Carlos Franco-Paredes; Steven K Ault; Mirta Roses Periago
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24
View more
  14 in total

Review 1.  Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey.

Authors:  Dagna Constenla; Cristina Garcia; Noah Lefcourt
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

Review 2.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

3.  Economic and disease burden of dengue in Mexico.

Authors:  Eduardo A Undurraga; Miguel Betancourt-Cravioto; José Ramos-Castañeda; Ruth Martínez-Vega; Jorge Méndez-Galván; Duane J Gubler; María G Guzmán; Scott B Halstead; Eva Harris; Pablo Kuri-Morales; Roberto Tapia-Conyer; Donald S Shepard
Journal:  PLoS Negl Trop Dis       Date:  2015-03-18

Review 4.  Human to mosquito transmission of dengue viruses.

Authors:  Lauren B Carrington; Cameron P Simmons
Journal:  Front Immunol       Date:  2014-06-17       Impact factor: 7.561

5.  The Burden of Dengue and the Financial Cost to Colombia, 2010-2012.

Authors:  Raúl Castro Rodríguez; Gabriel Carrasquilla; Alexandra Porras; Katia Galera-Gelvez; Juan Guillermo Lopez Yescas; Jorge A Rueda-Gallardo
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

6.  Household costs of dengue illness: secondary outcomes from a randomised controlled trial of dengue prevention in Guerrero state, Mexico.

Authors:  José Legorreta-Soberanis; Sergio Paredes-Solís; Arcadio Morales-Pérez; Elizabeth Nava-Aguilera; Felipe René Serrano-de Los Santos; Diana Lisseth Dimas-Garcia; Robert J Ledogar; Anne Cockcroft; Neil Andersson
Journal:  BMC Public Health       Date:  2017-05-30       Impact factor: 3.295

7.  Household costs for personal protection against mosquitoes: secondary outcomes from a randomised controlled trial of dengue prevention in Guerrero state, Mexico.

Authors:  José Legorreta-Soberanis; Sergio Paredes-Solís; Arcadio Morales-Pérez; Elizabeth Nava-Aguilera; Felipe René Serrano-de Los Santos; Belén Madeline Sánchez-Gervacio; Robert J Ledogar; Anne Cockcroft; Neil Andersson
Journal:  BMC Public Health       Date:  2017-05-30       Impact factor: 3.295

8.  Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine.

Authors:  Hanna El Fezzazi; Marie Branchu; Gabriel Carrasquilla; Punnee Pitisuttithum; Ana Paula Perroud; Carina Frago; Laurent Coudeville
Journal:  Am J Trop Med Hyg       Date:  2017-10-12       Impact factor: 2.345

9.  Dengue human infection models supporting drug development.

Authors:  James Whitehorn; Vinh Chau Nguyen Van; Cameron P Simmons
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

10.  Infection with dengue-2 virus alters proteins in naturally expectorated saliva of Aedes aegypti mosquitoes.

Authors:  Daniel M Chisenhall; Rebecca C Christofferson; Michael K McCracken; Ann-Marie F Johnson; Berlin Londono-Renteria; Christopher N Mores
Journal:  Parasit Vectors       Date:  2014-05-30       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.